2025-06-02 18:53:09
BioNTech shares rose 12% premarket after the company announced an $11 billion cancer collaboration with Bristol-Myers Squibb.
Email Subscription
Newsletters and emails are now available! Delivered on time, every weekday, to keep you up
to date with North American business news.
Weekly Highlights